• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气相色谱法对生物组织中挥发性氟烷代谢物的定量分析。

Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography.

作者信息

Maiorino R M, Sipes I G, Gandolfi A J, Brown B R

出版信息

J Chromatogr. 1979 Sep 11;164(1):63-72. doi: 10.1016/s0378-4347(00)81572-8.

DOI:10.1016/s0378-4347(00)81572-8
PMID:541398
Abstract

A simple and sensitive gas chromatographic method for the determination of 2-chloro-1, 1-difluoroethylene (CDE) and 2-chloro-1,1,1-trifluoroethane (CTE), two highly volatile metabolites of halothane, in blood, liver and isolated hepatic microsomes is described. The entire head-space in equilibrium with a known volume or weight of the sample is injected into the gas chromatograph equipped with a flame ionization detector. Quantification is accomplished with standards prepared by fortifying blank samples with known concentrations of CDE and CTE which are treated under the same conditions as the samples. Detection limits for CDE and CTE were 2 pmole/ml in blood and 10 pmole/g in liver and the mean relative standard deviations are no greater than +/- 6% except for CTE in hepatic microsomes (+/- 9%). A preliminary study of blood CDE and CTE levels in humans anesthetized with halothane is reported.

摘要

本文描述了一种简单且灵敏的气相色谱法,用于测定血液、肝脏及离体肝微粒体中氟烷的两种高挥发性代谢物——2-氯-1,1-二氟乙烯(CDE)和2-氯-1,1,1-三氟乙烷(CTE)。将与已知体积或重量的样品达到平衡的整个顶空部分注入配备火焰离子化检测器的气相色谱仪中。通过向空白样品中加入已知浓度的CDE和CTE制备标准品,并在与样品相同的条件下进行处理来完成定量分析。CDE和CTE在血液中的检测限为2皮摩尔/毫升,在肝脏中的检测限为10皮摩尔/克,除肝微粒体中的CTE(±9%)外,平均相对标准偏差不大于±6%。本文还报道了对接受氟烷麻醉的人体血液中CDE和CTE水平的初步研究。

相似文献

1
Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography.气相色谱法对生物组织中挥发性氟烷代谢物的定量分析。
J Chromatogr. 1979 Sep 11;164(1):63-72. doi: 10.1016/s0378-4347(00)81572-8.
2
Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.
Chem Biol Interact. 1984 Apr;49(1-2):121-32. doi: 10.1016/0009-2797(84)90056-5.
3
Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.体外人类氟烷还原代谢由细胞色素P450 2A6和3A4催化。
Drug Metab Dispos. 1996 Sep;24(9):976-83.
4
Modulation of the reductive metabolism of halothane by microsomal cytochrome b5 in rat liver.
Biochim Biophys Acta. 1987 Dec 7;926(3):231-8. doi: 10.1016/0304-4165(87)90208-x.
5
Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.氟烷代谢产物[14C]2-氯-1,1-二氟乙烯在肝微粒体中的代谢活化作用。
Drug Metab Dispos. 1988 Mar-Apr;16(2):169-72.
6
A comparative study on reductive dehalogenation of halothane in liver, kidney and lung of the rabbit.
Hiroshima J Med Sci. 1990 Dec;39(4):115-8.
7
The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.肝脏细胞色素P450对氟烷进行还原脱卤的机制。
Biochem Pharmacol. 1982 Feb 1;31(3):383-90. doi: 10.1016/0006-2952(82)90186-1.
8
Reductive metabolism of halothane by purified cytochrome P-450.
Biochem Pharmacol. 1988 Jun 15;37(12):2357-61. doi: 10.1016/0006-2952(88)90361-9.
9
Aerobic dehalogenation of halothane showing different substrate dependency from anaerobic dehalogenation in liver microsomes of guinea pig.
Hiroshima J Med Sci. 1991 Mar;40(1):23-8.
10
Volatile metabolites and decomposition products of halothane in man.氟烷在人体中的挥发性代谢物及分解产物。
Anesthesiology. 1979 Jan;50(1):2-8. doi: 10.1097/00000542-197901000-00002.

引用本文的文献

1
Isoflurane depresses glutamate release by reducing neuronal excitability at the Drosophila neuromuscular junction.异氟烷通过降低果蝇神经肌肉接头处的神经元兴奋性来抑制谷氨酸释放。
J Physiol. 2004 Jul 15;558(Pt 2):489-502. doi: 10.1113/jphysiol.2004.065748. Epub 2004 May 28.
2
Halothane anaesthesia and liver damage.氟烷麻醉与肝损伤。
Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1136-9. doi: 10.1136/bmj.289.6452.1136.
3
Drug hepatotoxicity.药物肝毒性。
Br J Clin Pharmacol. 1983 Jan;15(1):3-14. doi: 10.1111/j.1365-2125.1983.tb01456.x.